Next 10 |
home / stock / ipa:cc / ipa:cc news
VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already successful LENS ai TM Platform. LENS ai , which is run by the company's subsidiary, BioStran...
VICTORIA, BC / ACCESSWIRE/ April 12, 2024 / InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability and speed challenges partnered with ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), an artificial intelligence-dri...
VICTORIA, BC / ACCESSWIRE / March 8, 2024 / Anyone familiar with the intricacies of life science knows how truly complicated DNA is; without a full understanding of the language of DNA, scientists are often at a standstill when it comes to advanced medicine. That's why the work of companies like...
VICTORIA, BC / ACCESSWIRE / February 13, 2024 / Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly differe...
VICTORIA, BC / ACCESSWIRE / January 10, 2024 / ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, has recently provided an update to investors as it reported earnings for Q2 FY2024. The company is known for its pioneering wor...
VICTORIA, BC / ACCESSWIRE / December 7, 2023 / ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming financial reporting activities. At its recent Annua...
VICTORIA, BC / ACCESSWIRE / November 22, 2023 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented Generation (RAG)-based Large Language Model (L...
VICTORIA, BC / ACCESSWIRE / October 20, 2023 / Biotechnology research involves a vast amount of complex information that spans different dimensions, such as the functions of proteins, the 3D structures of molecules and the genetic information encoded in DNA. Understanding these various dimension...
VICTORIA, BC / ACCESSWIRE / October 13, 2023 / The introduction of artificial intelligence (AI) in healthcare has revolutionized the field, allowing for a more personalized approach to patient care. AI algorithms have the ability to process and analyze vast amounts of medical data, such as genet...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), an AI-driven biotherapeutic research and technology company, today announced that its subsidiary, BioStrand®, has successfully solved the Information Integration...
News, Short Squeeze, Breakout and More Instantly...
Immunoprecise Antibodies Ltd. Company Name:
IPA:CC Stock Symbol:
TSXVC Market:
VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already successful LENS ai TM Platform. LENS ai , which is run by the company's subsidiary, BioStran...
VICTORIA, BC / ACCESSWIRE/ April 12, 2024 / InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability and speed challenges partnered with ImmunoPrecise Antibodies (NASDAQ:IPA) ("IPA"), an artificial intelligence-dri...
VICTORIA, BC / ACCESSWIRE / March 8, 2024 / Anyone familiar with the intricacies of life science knows how truly complicated DNA is; without a full understanding of the language of DNA, scientists are often at a standstill when it comes to advanced medicine. That's why the work of companies like...